全球去腎神經導管市場 - 市場規模（按細分市場）、份額、監管、報銷、程序、預測（至 2033 年）

全球高血壓流行是去腎神經市場的最大驅動因素之一。 據估計，全世界有超過 10 億人患有高血壓，每年約有 940 萬人死於與高血壓相關的併發症。 除了不健康的生活習慣和人口老化之外，肥胖等代謝危險因子在高血壓盛行率上升中也扮演重要角色。

本報告研究分析了全球去腎神經導管市場，並提供了各細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 的影響等資訊。

市場模型的主要內容如下。

已上市的去腎神經導管和不斷變化的競爭格局

• 對主要產業趨勢的考慮
• 去腎神經導管市場按細分市場劃分的年收入和市場前景（2015-2033 年）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 去腎神經導管市場SWOT分析
• 去腎神經導管市場競爭動態的思考與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Medtronic Plc
• Boston Scientific Corp
• Abbott laboratories
• Otsuka Holdings Co Ltd
• 其他

Abstract

Renal Denervation Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Renal Denervation Catheters market for the year 2020 and beyond. Renal Denervation Catheters are also known as renal sympathetic denervation (RNSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in blood pressure in patients with resistant hypertension.

The global prevalence of hypertension is one of the largest drivers in the renal denervation market. It is estimated that over 1 billion people worldwide have hypertension and about 9.4 million deaths are associated with complications related to it every year. In addition to unhealthy lifestyle habits and a growing aging population, metabolic risk factors such obesity play an important role in the increasing prevalence of hypertension.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Renal Denervation Catheters and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Renal Denervation Catheters market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Renal Denervation Catheters market.
• Competitive dynamics insights and trends provided for Renal Denervation Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Boston Scientific Corp, Abbott laboratories, Otsuka Holdings Co Ltd, and Others.

Countries covered: United States, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Russia, Austria, Greece, Sweden, Switzerland, Australia, China, India, Japan, South Korea, Brazil, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Renal Denervation Catheters marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Renal Denervation Catheters market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Renal Denervation Catheters market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Renal Denervation Catheters market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Renal Denervation Catheters market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable